With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Dana-Farber/Children's Hospital Cancer Center Developmental Therapeutics Center of Excellence||Dana-Farber Cancer Institute / Steven DuBois, MD & Wendy London, PhD||Center of Excellence Grants||2012||Massachusetts|
|Pediatric Developmental Therapeutics Center of Excellence at UCSF||University of California San Francisco / Katherine Matthay MD, PI / Tiffany Chang MD, Scholar||Center of Excellence Grants||2012||California|
|Texas Children's Cancer Center Alex's Lemonade Stand Center of Excellence||Baylor College of Medicine / Stacey Berg, MD - Scholars: Jennifer Foster, MD, MPH and Ron Bernardi, MD,PhD||Center of Excellence Grants||2012||Texas|
|Alex's Lemonade Stand Foundation Center of Excellence in Childhood Cancer Drug Development and Clinical Pharmacology at The Children's Hospital of Philadelphia||Children's Hospital of Philadelphia / Elizabeth Fox, MD - Scholar: Ami Desai, MD||Center of Excellence Grants||2013||Pennsylvania|
|Novel Strategy for Reducing Radiation-Induced Morbidity and Treating Recurrent Medulloblasoma||Massachusetts General Hospital / Rakesh Jain, PhD||Reach Grants||2013||Massachusetts|
|Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma||Van Andel Research Institute / Patrick Grohar, MD, PhD||Reach Grants||2013||Michigan|
|Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma||Baylor College of Medicine / Cliona Rooney, PhD||Reach Grants||2013||Texas|
|LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma||University of Virginia, School of Medicine / Michael Engel, MD/PhD||Reach Grants||2016||Virginia|
|Targeting PLK1 as a Common Mechanism in Ph-like ALL||University of Texas M.D. Anderson Cancer Center / Joya Chandra, PhD||Reach Grants||2016||Texas|
|Moving EphB4 Therapeutics to Pediatric Phase I/II Trials||Oregon Health & Science University / Charles Keller, MD||Reach Grants||2013||Oregon|